Answers are grounded in this paper and cite their sources.
Screening FDA-approved oncology drugs revealed romidepsin’s effectiveness against osteosarcoma, suggesting its potential as a therapeutic candidate.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Seiden et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: